| Merck set for sixth day of declines after pulling European drug filing Umer Raffat, Evercore ISI senior analyst, discusses the volatility in Merck as shares plummet after withdrawing drug application for its lung cancer drug in Europe. | Feedback We value your input—use our simple form to let us know what you think. Click here for Real-Time data and top stories on your desktop or mobile device. |
| |  © 2017 CNBC Inc. All Rights Reserved. 900 Sylvan Avenue, Englewood Cliffs, NJ 07632 |
| |